期刊文献+

维持性血液透析患者血红蛋白的变异性和死亡相关 被引量:10

Hemoglobin variability is associated with mortality in patients on maintenance hemodialysis
下载PDF
导出
摘要 目的 探讨维持性血液透析(maintenance hemodialysis,MHD)患者血红蛋白变异性和全因死亡之间的关系. 方法 收集2007年7月至2012年12月上海市透析登记系统中登记的364例上海交通大学医学院附属仁济医院MHD患者一般情况、生化指标以及预后.评估血红蛋白的变异性[血红蛋白标准差(SD)、变异系数(CV)]与全因死亡之间的关系.结果 364例患者平均年龄63.07±13.93岁,平均透析龄76.0 (42.25,134.0)月,死亡患者85例占23.4%.MHD死亡患者平均血红蛋白SD和CV较高[分别为19.19±6.31比13.74±5.89和0.172±0.07比0.126±0.056,P均<0.001],与存活患者相比均有统计学差异.血红蛋白SD大于P75(上四分位数)组,其发生全因死亡的危险显著高于SD小于P25(上四分位数)组患者[OR=5.964,95% CI(2.663~13.357),P<0.001].校正了年龄、性别、生活方式和生化指标后,两者结果相同[OR=4.961,95% CI (1.959~11.238),P<0.001].Kaplan-Meier分析显示血红蛋白SD和CV小于P25患者其生存率显著低于P75组患者(P均<0.001).ROC曲线下面积(AUC)显示血红蛋白SD、CV预测MHD患者全因死亡的AUC分别为0.677g/1和0.721(当截断点为10.647和0.1086时,其敏感性为89.4%和85.1%,特异性为67.7%和60.3%,P<0.001).多因素Logistic回归分析显示血红蛋白CV升高、年龄增加和CRP升高是MHD患者全因死亡独立危险因素.结论 MHD患者血红蛋白的变异性较大患者具有较高死亡危险度,血红蛋白的变异性可能有助于MHD患者全因死亡的预测. Objective To determine the relationship between hemoglobin variability and mortality in maintenance hemodialysis (MHD) patients.Methods A total of 364 MHD cases were recruited from Shanghai Renal Registry Network.The relationship between hemoglobin variability and all-cause mortality was assessed.Results In the 364 MHD cases,the average age was 63.07±13.93 years,the dialysis vintage was 76.0 (42.25,134.0) months,and 85 patients (23%) died.The dead patients had a higher mean hemoglobin SD and CV comparing with the survival patients (19.19±6.31 vs.13.74±5.89,and 0.172±0.07 vs.0.126±0.056,respectively,P<0.001).Risk of all-cause mortality in patients in the upper quartile (P75) of hemoglobin SD was significantly higher than those in the lower quartile (P25) (OR=5.964,95% CI 2.663 ~ 13.357,P< 0.001),even after adjustment for demographic data,lifestyle factors and biochemical markers (OR=4.961,95% CI 1.959~ 11.238,P<0.001).Kaplan-Meier method showed that patients with hemoglobin SD and CV in the upper quartile had a lower survival rate (P< 0.001).ROC-AUC of hemoglobin SD and CV for all-cause mortality were 0.677 and 0.721,respectively (cutoff 10.647g/1 and 0.1086,respectively; accuracy 89.4% and 85.1%,respectively; specificity 67.7% and 60.3%,respectively; P<0.001).Multivariate logistic regression analysis showed that higher hemoglobin CV,older age and higher CRP were the independent risk factors for all-cause mortality.Conclusions The highest hemoglobin SD and CV were independently correlated with all-cause mortality.Hemoglobin variability may have prediction value for mortality in MHD patients.
出处 《中国血液净化》 2014年第1期12-16,共5页 Chinese Journal of Blood Purification
关键词 维持性血液透析 血红蛋白 变异性 Maintenance hemodialysis Hemoglobin Variability
  • 相关文献

参考文献15

  • 1Weiss G, Goodnough LT. Anemia of chronic disease[J].N Engl J Med, 2005, 352:1011-102.
  • 2Alfrey CP, Fishbane S. implications of neocytolysis for optimal management of anaemia in chronic kidney disease[J]. Nephron Clin Pract, 2007, I06:c149-156.
  • 3Lacson E Jr, Ofsthun N, Lazarus ]M. Effect of variabil ity in anemia management on hemoglobin outcomes in ESRD [J]. Am J Kidney Dis, 2003, 41:iii-124.
  • 4Boudville NC, Djurdjev O, Macdougall IC et al. Hemoglo bin variability in nondialysis chronic kidney dis- ease: examining the association with mortality[J]. Clin J Am Soc Nephrol, 2009, 4:1176-1182.
  • 5Holzel WG. Intra-individual variation of some analytes in serum patients with insulin-dependent diabetes mellitus[J]. Clin Chem, 1987, 33:57-61.
  • 6Yang W, Israni RK, Brunelli SM et al. Hemoglobin vari ability and mortality in ESRD[J]. J Am Soc Nephrol, 2007, 18:3164-3170.
  • 7Brunelli SM, Lynch KE, Ankers ED et al. Association of hemoglobin variability and mortality among contem porary incident hemodialysis patients[J]. Clin J Am Soc Nephrol, 2008, 3:1733-1740.
  • 8Brunelli SM, Joffe :, Israni RE et al. History adjust- ed marginal structural analysis of the association be- tween hemoglobin variability and mortality among chron- ic hemodialysis patients[J]. Clin J Am Soc Nephrol, 2008, 3:777-782.
  • 9Gilbertson DT, Ebben JP, Foley RN et al. Hemoglobin level variability: associations with mortality[J]. Clin J Am See Nephrol, 2008, 3:133-138.
  • 10程艳娇,王梅.血红蛋白变异性与透析患者预后的关系[J].中华肾脏病杂志,2013,29(4):253-257. 被引量:21

二级参考文献17

  • 1KDOQI. KDOQI Clinical Practice Guideline and ClinicalPractice Recommendations for anemia in chronic kidneydisease: 2007 update of hemoglobin target. Am J Kidney Dis,2007,50: 471-530.
  • 2Bems JS, Elzein H, Lynn RI, et al. Hemoglobin variability inepoetin - treated hemodialysis patients. Kidney Int, 2003, 64:1514-1521.
  • 3Szeto CC, Kwan BC, Chow KM, et al. Haemoglobin variabilityin Chinese pre - dialysis CKD patients not receivingerythropoietin. Nephrol Dial Transplant, 2011,26: 2919-2924.
  • 4Wish JB. Hemoglobin variability as a predictor of mortality:What's a practitioner to do? Am J Kidney Dis, 2011, 57: 190-193.
  • 5SINGH A K, SZCZECH L, TANG K L, et al. Correction ofanemia with epoetin alfa in chronic kidney disease. New EnglJ Med, 2006, 355: 2085-2098.
  • 6Lea JP, Norris K, Agodoa L. The role of anemia managementin improving outcomes for African - Americans with chronickidney disease. Am J Nephrol, 2008,28: 732-743.
  • 7Kalantar - Zadeh K, Aronoff GR. Hemoglobin variability inanemia of chronic kidney disease. J Am Soc Nephrol, 2009,20: 479-487.
  • 8Boudville NC,Djurdjev 0,Macdougall IC,et al. Hemoglobinvariability in nondialysis chronic kidney disease: examiningthe association with mortality. Clin J Am Soc Nephrol, 2009,4: 1176-1182.
  • 9Yang W,Israni RK, Brunelli SM, et al. Hemoglobin variabilityand mortality in ESRD. J Am Soc Nephrol, 2007, 18: 3164-3170.
  • 10Brunelli SM, Joffe MM, Israni RK, et al. History - adjustedmarginal structural analysis of the association betweenhemoglobin variability and mortality among chronichemodialysis patients. Clin J Am Soc Nephrol, 2008, 3: 111 -782.

共引文献20

同被引文献73

引证文献10

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部